黄芪注射液联合参麦注射液治疗青年病毒性心肌炎的临床观察  

Clinical observation of treatment of Viral Myocarditis by Huangqi injection combined with Shenmai injection

作　　者：严军虎[1] 张淑娟[2] 

机构地区：[1]陕西师范大学医院,陕西西安710062 [2]陕西能源职业技术学院医学校区,陕西西安710613

出　　处：《中医临床研究》2015年第24期74-75,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:探讨参脉注射液联合黄芪注射液治疗病毒性心肌炎的临床效果。方法:将65例住院的青年病毒性心肌炎患者,随机分为对照组(21例):给予常规西药治疗;治疗组(22例):在对照组的基础上给予黄芪注射液治疗;实验组(22例):在对照组的基础上给予黄芪注射液联合参脉注射液治疗。观察比较三组疗效。结果:治疗组综合疗效显著优于对照组,实验组综合疗效显著优于治疗组,三组数据差异具有统计学意义(P<0.05)。结论:参脉注射液联合黄芪注射液治疗病毒性心肌炎能有效改善患者临床症状,促进心电图恢复,提高综合治疗效果,值得推广。Objective： To explore the clinical effect of Shenmai injection combined with Huangqi injection on viral myocarditis. Methods： 65 cases with viral myocarditis in hospital were randomly divided into a control group （21 cases） treated with conventional western medicine treatment and a treatment group （22 cases） treated with Huangqi injection on the basis of the therapies for the control group and an experimental group （22 cases） treated with Shenmai injection combined with Huangqi injection on the basis of the therapies for the control group. The effects of the three groups were compared. Results： The curative effect of the treatment group was significantly better than that of the control group, the experimental group was better than that of the treatment, there were statistically significant difference between the three groups （P〈0.05）. Conclusion： Shenmai injection combined with Huangqi injection can effectively improve the symptoms of viral myoearditis, promote the electrocardiogram recovery, which is worthy of clinical popularization and application.

关 键 词：黄芪注射液 参脉注射液 病毒性心肌炎 临床疗效 

分 类 号：R259[医药卫生—中西医结合]